Despite the positive results, there are open questions about LBB pacing, including long-term lead performance. RCTs are ...

Omniasecure, which was authorized for placement in the heart’s right ventricle, is the world’s smallest defibrillation lead, ...

Medtronic (NYSE: MDT) announced that it received FDA approval for its OmniaSecure defibrillation lead for right ventricle ...

Medtronic (NYSE: MDT) announced that it entered into an agreement to distribute the Retia Medical Argos cardiac output ...

Medtronic confirmed that its Hugo surgical robot system has been submitted to the FDA for review, alongside the successful completion of a large clinical trial evaluating its performance in multi ...

Medtronic said its OmniaSecure device can be used to treat potentially life-threatening conditions including ventricular tachyarrhythmias, a heart rhythm disorder where the heart's lower chambers beat ...

Medtronic received approval for its OmniaSecure ... has the potential to enable physiologic pacing to more closely mimic the heart's natural conduction system, it said.

The lead, built on the highly reliable SelectSecure Model 3830 pacing lead and delivered via catheter, builds on the Medtronic portfolio of lead solutions designed for precise delivery and placement.

The US Food and Drug Administration (FDA) has granted approval for Medtronic’s OmniaSecure defibrillation lead intended for ...

The first-ever pacemaker to include Managed Ventricular Pacing (MVP®), the EnRhythm™ Pacing System promotes intrinsic conduction and is clinically proven to significantly reduce unnecessary ...

Sammy Tangui, the pacemaker for Olympic 800-metre champion David Rudisha, told the Courier Mail he earned between $2,000 (£1,500) and $3,000 (£2,250) per race. How Kelvin Kiptum went from having ...

(RTTNews) - Medtronic (MDT) revealed that its Expand URO Investigational Device Exemption (IDE) clinical study, the most extensive of its kind for robotic-assisted urologic surgery, successfully ...